循环microRNA水平可预测1型糖尿病儿童的残余β细胞功能与血糖控制
在123例新发1型糖尿病儿童中,于诊断后1、3、6、12和60个月采集血浆并检测microRNA。结果显示,诊断后3个月时的hsa-miR-197-3p可预测12个月时的刺激后C肽水平,hsa-miR-24-3p和hsa-miR-146a-5p水平与12个月时IDAA1c降低相关。
要点
- 3个月时hsa-miR-197-3p水平翻倍对应12个月刺激后C肽水平高6倍。
- 3个月时hsa-miR-24-3p和hsa-miR-146a-5p水平翻倍分别对应12个月IDAA1c降低4.2%和3.5%。
- hsa-miR-197-3p是诊断后1年残余β细胞功能的最强预测因子。
核心结论
- 诊断后3个月时的hsa-miR-197-3p是1型糖尿病儿童诊断后1年残余β细胞功能的最强预测因子。
研究设计与样本
- 研究纳入123例新发1型糖尿病儿童,其中40例来自丹麦缓解期队列的子集用于发现分析,剩余83例用于验证分析。
- 在诊断后1、3、6、12和60个月前瞻性采集血浆样本检测microRNA,同时测量餐刺激后C肽和HbA1c并计算IDAA1c。
- 采用校正年龄和性别的多元线性回归分析microRNA对疾病进展的预测作用。
主要发现
- 发现分析中,3个月时的6种microRNA(hsa-miR-24-3p、hsa-miR-146a-5p、hsa-miR-194-5p、hsa-miR-197-3p、hsa-miR-301a-3p和hsa-miR-375)与诊断后6-12个月的残余β细胞功能相关。
- 3个月时的hsa-miR-197-3p可预测12个月时的刺激后C肽水平(p = 0.034),该microRNA水平翻倍对应刺激后C肽水平高6倍。
- 3个月时hsa-miR-24-3p和hsa-miR-146a-5p水平翻倍分别对应12个月时IDAA1c降低4.2%(p < 0.014)和3.5%(p < 0.022)。
- 在剩余队列中验证了hsa-miR-197-3p的初始发现(p = 0.018)。
- 6种microRNA的靶基因在促性腺激素释放激素受体和血管生成通路中显著富集。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We aimed to identify circulating microRNA (miRNA) that predicts clinical progression in a cohort of 123 children with new-onset type 1 diabetes mellitus. METHODS: Plasma samples were prospectively obtained at 1, 3, 6, 12 and 60 months after diagnosis from a subset of 40 children from the Danish Remission Phase Cohort, and profiled for miRNAs. At the same time points, meal-stimulated C-peptide and HbA1c levels were measured and insulin-dose adjusted HbA1c (IDAA1c) calculated. miRNAs that at 3 months after diagnosis predicted residual beta cell function and glycaemic control in this subgroup were further validated in the remaining cohort (n = 83). Statistical analysis of miRNA prediction for disease progression was performed by multiple linear regression analysis adjusted for age and sex. RESULTS: In the discovery analysis, six miRNAs (hsa-miR-24-3p, hsa-miR-146a-5p, hsa-miR-194-5p, hsa-miR-197-3p, hsa-miR-301a-3p and hsa-miR-375) at 3 months correlated with residual beta cell function 6-12 months after diagnosis. Stimulated C-peptide at 12 months was predicted by hsa-miR-197-3p at 3 months (p = 0.034). A doubling of this miRNA level corresponded to a sixfold higher stimulated C-peptide level. In addition, a doubling of hsa-miR-24-3p and hsa-miR-146a-5p levels at 3 months corresponded to a 4.2% (p < 0.014) and 3.5% (p < 0.022) lower IDAA1c value at 12 months. Analysis of the remaining cohort confirmed the initial finding for hsa-miR-197-3p (p = 0.018). The target genes for the six miRNAs revealed significant enrichment for pathways related to gonadotropin-releasing hormone receptor and angiogenesis pathways. CONCLUSIONS/INTERPRETATION: The miRNA hsa-miR-197-3p at 3 months was the strongest predictor of residual beta cell function 1 year after diagnosis in children with type 1 diabetes mellitus.
引用
- Samandari N, Mirza AH, Nielsen LB, et al. Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus. Diabetologia. 2016. PMID: 27866223. doi:10.1007/s00125-016-4156-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。